magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Online: 2575-7970 Downloads: 247123 Total View: 2681536
Frequency: quarterly ISSN Print: 2575-7989 CODEN: IJCEMH
Email: ijcemr@hillpublisher.com
Article Open Access http://dx.doi.org/10.26855/ijcemr.2025.01.023

Clinical Effects of Microecological Agents on Intestinal Dysbacteriosis in Patients with Pancreatic Cancer

Zheng Liu, Meng Liang, Nan Zhang*

Hebei University Affiliated Hospital, Baoding 071000, Hebei, China.

*Corresponding author: Nan Zhang

Published: February 27,2025

Abstract

Objective: To evaluate the clinical efficacy of microecological agents in the treatment of intestinal dysbacteriosis in patients with pancreatic cancer. Methods: A total of 60 patients with pancreatic cancer and intestinal dysbacteriosis admitted to our hospital from June 1, 2023, to May 31, 2024, were enrolled in this study. They were randomly divided into two groups: the conventional treatment group (n = 30) and the microecological agent group (n = 30). The conventional treatment group received standard treatment, while the microecological agent group received additional treatment with microecological agents. The therapeutic effects and safety were compared between the two groups. Results: Before treatment, there were no significant differences in laboratory indicators between the two groups (P > 0.05). After treatment, the laboratory indicators decreased in both groups, with a more pronounced de-crease observed in the microecological agent group (P < 0.05). The clinical indicators of the microecological agent group were significantly lower than those of the conventional treatment group after treatment (P < 0.05). Additionally, the incidence of adverse reactions in the microecological agent group was significantly lower than that in the conventional treatment group (P < 0.05). Conclusion: Compared with conventional treatment alone, the administration of microecological agents in patients with pancreatic cancer and intestinal dysbacteriosis results in more pronounced therapeutic effects. It can significantly reduce laboratory indicators, shorten defecation and hospitalization time, and accelerate the relief of symptoms and signs, with high safety. Therefore, this treatment approach is worthy of clinical promotion.

References

[1] Shi P, Fu X, Pan L, Ye M. Study on the Effect of Early Enteral Nutrition Combined with Microecological Agents on Intestinal Flora in Children with Acute Pancreatitis Based on Metagenomics. Chin J Birth Health Hered. 2024;32(9):1943-51.

[2] Zhao P, Wang C. Standardized and Normalized Diagnosis and Treatment Series of Malignant Tumors: Pancreatic Cancer Volume. Beijing: People's Medical Publishing House; 2011.

[3] Zhou T. Clinical Microbiology Diagnosis and Illustration. 2nd ed. Shanghai: Shanghai Scientific and Technical Publishers; 2007.

[4] He Q, Qian G, Zhang X, et al. Application Effect of Enteral Nutrition Support with Microecological Immunomodulators in the Treatment of Acute Infectious Necrotizing Pancreatitis. Chin J Nosocomiol. 2024;34(22):3402-7.

[5] Wang L, Li Q, Yang P, et al. Study on the Effect of Intestinal Microecological Adjustment on Serum TMAO Level, Coagulation Function, and Prognosis in Patients with Acute Pancreatitis. Mod Dig Interv Ther. 2024;29(5):582-6.

[6] Xie G, Zhang Y, Guo X, et al. Study on the Differences in Intestinal Flora Structure and Functional Variations in Patients with Damp-Heat Syndrome of Pancreatic Cancer Based on High-Throughput Sequencing Technology. Shanghai J Tradit Chin Med. 2019;53(12):9-16.

[7] Chen Z, Qian X, Zhang A, et al. Study on the Correlation between Different Traditional Chinese Medicine Syndromes and Prognosis of Pancreatic Cancer Based on the Characteristics of Intestinal Flora Structure. Zhejiang J Integr Tradit Chin West Med. 2019;29(12):965-9, Frontispiece 1.

[8] Gou F, Jia J, Zhang T, et al. Risk Factors for Secondary Intra-abdominal Infection After Pancreatic Cancer Surgery and the Relationship between Intestinal Flora Dysbiosis, Interferon-Stimulated Gene Protein, and Endotoxin Levels. Chin J Nosocomiol. 2023;33(1):76-80.

[9] Yin Z, Peng X, Lin Y, et al. Causality between Intestinal Flora and Its Metabolic Pathways and Pancreatic Cancer: A Two-Sample Mendelian Randomization Analysis. J Hainan Med Univ. 2024;30(22):1727-34.

How to cite this paper

Clinical Effects of Microecological Agents on Intestinal Dysbacteriosis in Patients with Pancreatic Cancer

How to cite this paper:  Zheng Liu, Meng Liang, Nan Zhang. (2025) Clinical Effects of Microecological Agents on Intestinal Dysbacteriosis in Patients with Pancreatic Cancer. International Journal of Clinical and Experimental Medicine Research9(1), 143-147.

DOI: http://dx.doi.org/10.26855/ijcemr.2025.01.023